Algo version: 0.98b
Wai Chun Bio-Technology is listed at the HKSE Exchange
Wai Chun Bio-Technology [0660.HK]
HKSE Sector: Industry:Chemicals

Is Wai Chun Bio-Technology stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Wai Chun Bio-Technology 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was HKD4.50, you would have made a loss of HKD-4.42 per share or -98.22%

No, the average daily trading liquidity for Wai Chun Bio-Technology is HKD26 440 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Wai Chun Bio-Technology has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.65, the company's ability to pay off the debt is good. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Wai Chun Bio-Technology to be medium [0.6 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.